MAX BioPharma

Feb 20, 2025

Metaba and MAX BioPharma Announce Breakthrough Progress on Next-Generation Oxysterol-Based Antibiotics

Feb 26, 2024

MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies

Feb 02, 2021

MAX BioPharma Announces Key Discoveries Regarding Oxysterol Drug Candidates for Targeting Covid-19

Mar 03, 2020

MAX BioPharma Announces Key Update to its Liver Fibrosis Program Showing Efficacy of an Oxysterol Lead Drug Candidate in Inhibiting NASH in a Humanized Mouse Model